TRAVERE THERAPEUTICS, INC. Accrued Professional Fees, Current
TRAVERE THERAPEUTICS, INC. (TVTX) had Accrued Professional Fees, Current of $498.00 thousand as of 2016-03-31, per its 10-Q filed 2016-05-05.
Discontinued › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedProfessionalFeesCurrent · last filed 2016-05-05
- 2016-03-31: Accrued Professional Fees, Current $498.00K.
- 2015-12-31: Accrued Professional Fees, Current $882.00K.
- 2015-09-30: Accrued Professional Fees, Current $1.19M.
- 2014-12-31: Accrued Professional Fees, Current $1.21M.
| Period end | Accrued Professional Fees, Current |
|---|---|
| 2016-03-31 | $498.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $882.00K 10-Q · filed 2016-05-05 |
| 2015-09-30 | $1.19M 10-Q · filed 2015-11-06 |
| 2014-12-31 | $1.21M 10-K · filed 2016-02-26 |
| 2013-03-31 | $0.00 10-Q/A · filed 2013-09-16 |
| 2012-12-31 | $563.38K 10-Q/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |